Introduction P-selectin is an integral membrane C-type lectin found within the Weibel-Palade bodies of endothelial cells (McEver et al., 1989; Bonfanti et al., 1989) and the a granules of platelets (Hsu-Lin et al., 1984; Stenberg et al., 1985) . Its translocation to the plasma membrane can be induced by thrombin (Hsu-Lin et al., 1984; Stenberg et al., 1985) , histamine, and other mediators released by mast cell activation (Hattori et al., 1989a; Kubes and Kanwar, 1994; Thorlacius et al., 1994) complement C5b-9 complex or C5a fragment (Hattori et al., 1989b; Foreman et al., 1994) , and peroxides (Pate1 et al., 1991) . Once displayed on the cell surface, P-selectin supports the attachment of myelomonocytes to platelets (Larsen et al., 1989; Hamburger and McEver, 1990) or endothelial cells (Geng et al., 1990; Gamble et al., 1990) . In the latter setting, its appearance heralds an underlying tissue insult and supports the initial step in leukocyte extravasation, the rolling of neutrophils along the postcapillary venule wall (Lawrence and Springer, 1991) . Mice homozygously deficient for the P-selectin structural gene exhibit deficits in leukocyte rolling and show delayed recruitment of granulocytes to sites of experimentally induced inflammation (Mayadas et al., 1993) .
If there is a unifying theme to the pattern of mediators that induce P-selectin expression, it is the integration of signals that commonly arise in the context of trauma or wounding. One of the first recognized responses to tissue trauma is mast cell activation, which is accompanied by release of histamine, serotonin, and other diffusible mediators. Although induction of P-selectin-mediated neutrophil rolling has been thought to be an inevitable consequence of surgical intervention, cromolyn, an agent that blocks mast cell degranulation, has been shown to prevent such rolling, thereby providing an elegant demonstration of the role of the mast cell as the link between trauma and extravasation (Kubes and Kanwar, 1994) .
Much is presently known about the residues on P-selectin that are important for binding (Hollenbaugh et al., 1993; Erbeet al., 1993; Bajorathet al., 1994; Kansaset al., 1994; Murphy and McGregor, 1994) , but the precise structure on human neutrophils that serves as a ligand has proven elusive. Soluble human P-selectin chimeras recognize a specific homodimeric counterreceptor that bears sialylated, fucosylated O-linked glycans (Moore et al., 1992 (Moore et al., , 1994 . A cDNA encoding this counterreceptor, termed P-selectin glycoprotein ligand 1 (PSGL-1) (Sako et al., 1993) was isolated by expression cloning in COS cells cotransfected with a fucosyltransferase, FTIII (Kukowska-Latallo et al., 1990) , known to give rise to Lewis X (Le"), sialyCLewis X (sLe"), Lewis A (Lea), and sialyl-Lewis A (sLe") glycans. Thus, reconstitution of the neutrophil ligand for P-selectin in COS cells requires at least two elements, an enzyme to supply fucose and a specific protein backbone (PSGL-1). PSGL-1 has typical features of an integral membrane mucin, but appears to be uniquely suited for interaction with P-selectin because expression of other mucins in COS cells in the presence of the same fucosyltransferase does not support P-selectin binding (Sako et al., 1993) .
In addition to fucose and PSGL-1, additional components of the P-selectin ligand may be inapparent because of their constitutive production in COS cells. For example, both sialic acid and sulfate may be necessary for binding. Neuraminidase treatment of target cells significantly attenuates binding to P-selectin (Corral et al., 1990; Moore et al., 1991) whereas suppression of sulfation on HL-60 cells by exposure to sodium selenate has effects of similar potency (Aruffo et al., 1991) . These results raise the possibility that both sulfation in some form and the sLeX determinant are components of the target structure recognized by P-selectin.
Less is known about P-selectin ligands in mice, but a 160 kDa protein has been identified on neutrophils that binds selectively to a murine P-selectin-immunoglobulin chimera (Lenter et al., 1994) suggesting that specific protein scaffolds may also be required for binding. The murine chimera also recognizes some but not all glycoforms of a low molecular weight mucin-like molecule called CD24-heat stable antigen (Sammar et al., 1994) . A correlation was found between those isoforms showing P-selectin binding and those reacting with an antibody recognizing a complex glycan bearing sulfate and glucuronic acid, known as HNK-1 (Sammar et al., 1994) .
An important topic that remains to be addressed is the Figure  1A ) were transfected into COS cells in the presence of a myeloid fucosyltransferase, FTVII, which directs the expression of sLe" determinants exclusively (Sasaki et al., 1994; Natsuka et al., 1994 (Pallant et al., 1989; Shelley et al., 1989 Figure  2C ; data not shown). The PSGL-1 N-terminus is stippled, the transmembrane domains are shown hatched, and a representative repeat is shown densely stippled. The PSGL-1 N-terminus was fused to the N-terminus of the predicted mature CD34 and GlyCAM-1 and to the N-terminus of the repeat region of CD43. (Shelley et al., 1989) and 100 kDa (Simmons et al., 1992) , respectively, whereas the PSGL-1 monomer exhibits an effective molecular mass of 110 kDa (Sako et al., 1993) . GlyCAM-1, in its native (untethered) state, comigrates with 50 kDa proteins (Lasky et al., 1992) . Although it has not been established at present whether a precise estimate of the molecular mass of a mucin-like protein can be achieved by measurement of relative mobility in polyacrylamide gels, nor the appropriate migrationmass relationship, the larger mucins appear to be able to support P-selectin binding when the apical domain of PSGL-1 is appended to the amino terminus.
To explore the possibility that sulfation might be one determinant of the ability of other mucins to support apical domain-directed binding, we evaluated the potential of the different mucins above to undergo sulfation in COS cells. PSGL-1, CD34, CD43, and GlyCAM-1 soluble mucin chimeras readily incorporated sodium [%]sulfate when expressed in COS cells (Figure 3 ).
Sequential deletion of the internal repeat elements of PSGL-1 allows one to shorten the molecule in a regular and systematic way with relatively little danger of compromising hypothetical global tertiary associations. As repeat elements were deleted, the binding activity of PSGL-1 declined, consistent with the idea that distance from the plasma membrane might be an important determinant of P-selectin-binding activity (data not shown). Alternatively, other factors, such as carbohydrate density, may contribute to P-selectin binding efficacy.
Inhibition
of Sulfation Blocks PSGL-1 Binding to P-Selectin
In previous studies, the sulfation inhibitor sodium selenate was found to compromise binding of HL-60 cells to soluble P-selectin significantly, while having little or no effect on binding of the cells to soluble E-selectin (Aruffo et al., 1991 relatively selective inhibitor of sulfation (Baeuerle and Huttner, 1986) was effective. COS cells were cotransfected with PSGL-1 and FTVII, or transfected with PSGL-1 and FTVII separately, and incubated for the time period during which maximum synthesis of PSGL-1 was expected in a modified DMEM medium lacking sulfate and containing 10 mM sodium chlorate. Under these conditions, we observed a significant decrease in the ability of cotransfected cells to bind to immobilized P-selectin, whereas the same cells showed little or no decrement in binding to immobilized E-selectin ( Figures 4A and 48 ). The cell surface expression of either the sLex antigen or the PSGL-1 aminoterminal tag sequence was not compromised by this treatment ( Figure 4C ). Rather, an increase in the mean fluorescence intensity of the transfected cells, for both antisle" and anti-flu tag, was observed following chlorate treatment. At present, the explanation for this is uncertain. A soluble PSGL-1 immunoglobulin chimera synthesized under comparable conditions showed essentially complete inhibition of [%]sulfate incorporation ( Figure 4D ) under conditions in which protein synthesis, as measured by [35S]cysteine and methionine incorporation, was not inhibited ( Figure 4E ).
Fine Structure Deletion Analysis of the Apical Domain of PSGL-1 To localize elements of the apical domain that contribute to P-selectin counterreceptor activity, we prepared a series of finer deletions across the apical domain, again placing each amino-terminal deletion downstream from the CD5 leader/flu tag element to monitor cell surface expression ( Figure 5A ). Removal of 20 amino acids from the predicted mature N-terminus had no effect on P-selectinbinding activity, whereas removal of 40 amino acids abrogated binding ( Figure 5B ). As was the case for the gross deletions, fine structure deletions showed little variability in expression of the epitope tag as assessed by indirect immunofluorescence(Figure5C).
Furtherdeletion gave no change in activity. Thus, sequences between amino acid residues 20-40 (residues 38-57 of the predicted precursor) appear to be required for P-selectin binding. Numbering corresponds to residues in the PSGL-1 precursor (Sako et al., 1993 Figure   6A ). In both cases, the addition of this short peptide element conferred P-selectin-binding activity upon the mucin core that was equivalent to that of native PSGL-1 ( Figure  6C ). Residues within the Amino-Terminal 20 Amino Acids Are Sulfated on Tyrosine To determine whether the amino-terminal segment was capable of being sulfated in vivo, we created fusion proteins consisting of the native or mutant peptide sequences joined to human immunoglobulin Gl (IgGl) ( Figure 7A ). The resulting fusion proteins were expressed in COS cells (Figure 78) , and their ability to assimilate inorganic sulfate was assessed. lmmunoglobulin chimeras bearing the native peptide sequences were capable of incorporating sulfate, whereas those bearing phenylalanine substituted for tyrosine were not ( Figure 7C ). Replacement of threonine with alanine had no effect on sulfate incorporation (Figure 7C) .
Inhibitors of Sulfation Block HL-60 Rolling on P-Selectin-lmmunoglobulin Chimeras To explore whether inhibition of sulfation would compromise a physiologically relevant adhesion, we subjected HL-60 cells to growth in medium containing chlorate and examined the ability of the resulting cells to attach and roll on coverslips coated with P-selectin-immunoglobulin chimeras under conditions of defined fluid shear stress A (Lawrence et al., 1990) . HL-60 cells were capable of attaching to and rolling upon coverslips precoated with P-selectin-immunoglobulin chimera, whereas no such interactionwasobserved with coverslips coated with aCD4-immunoglobulin chimera (Figure 8 ; data not shown). Growth of HL-60 cells in chlorate dramatically reduced the frequency of cell interaction with the substrate (Figure 8 ).
Discussion
The selectin family of cell surface lectins mediates the initial phase of leukocyte-endothelial adhesion, the rolling of cells along activated endothelium (von Andrian et al., 1991; Lawrence and Springer, 1991) . Members of the family share a common facility for the recognition of glycans bearing sLeX determinants (Foxall et al., 1992) . However, there are clear differences in the target recognition patterns of the different selectins. E-selectin mediates the binding of both hematopoietic and nonhematopoietic cells bearing sLeX in a large number of different glycan and protein scaffold contexts (Lowe et al., 1990; Walz et al., 1990; Phillips et al., 1990) , suggesting that many proteins The same constructs were tested as in (B), except that a control fusion protein bearing no amino-terminal addition (lane B) was included. Lanes C through G correspond to B through F in (B).
may be capable of presenting sLex to E-selectin. These findings do not exclude the possibility that specific proteins on neutrophils are selectively endowed with SLe", or possess an enhanced capacity to interact with E-selectin by virtue of their localization to plasma membrane microvilli. Two candidate scaffold proteins that may have superior capacity to present sLex to E-selectin are L-selectin on human neutrophils (Picker et al., 1991) and ESL-1, a protein related to fibroblast growth factor, on a murine granulocytic cell line (Steegmaier et al., 1995) . In contrast, P-selectin binding cannot be documented in cells transfected with fucosyltransferases alone, nor in nonhematopoietic cells expressing sLex. A major advance in the understanding of P-selectin specificity was the identification of PSGL-1, which has a unique ability (among human neutrophil surface proteins) tosupport an adhesive interaction with P-selectin (Moore et al., 1992 (Moore et al., , 1994 Sako et al., 1993) . This interaction was shown to require specific glycan modifications that could include sLex.
The fucosyltransferase employed for the isolation of PSGL-1 cDNA by expression cloning, FTIII, is a mixed specificity enzyme that synthesizes Lex, sLex, Lea, and sLea (Kukowska-Latalloet al., 1990) . In thisstudy, we have demonstrated that coexpression of PSGL-1 in COS cells with the highly specific myeloid lineage enzyme FTVII, which synthesizes sLex exclusively (Sasaki et al., 1994; Natsuka et al., 1994) , is sufficient for acquisition of P-selectin-binding activity. Thus, it appears that sLex is necessary for PSGL-1 cofactor activity and suffices for that activity when it is the only exogenous glycosyltransferase coexpressed with PSGL-1 in COS cells. The necessity for other posttranslational modifications of PSGL-1 that may be required to support P-selectin binding, however, is not ruled out by these studies.
Both L-and P-selectin are known to bind anionic polymers, L-selectin by mannose8-phosphate polymers, fucoidan, heparin, and related saccharides (Stoolman and Rosen, 1983; Stoolman et al., 1984; Norgard-Sumnicht et al., 1993; Nelson et al., 1993) , and P-selectin by heparin, heparan sulfate, dextran sulfate, and fucoidan (Skinner et al , 1991 Aruffo et al., 1991) , as well as related compounds and anionic inositides (Nelson et al., 1993; Cecconi et al., 1994) . Both selectins interact strongly with sulfatides (Watson et al., 1990; lmai et al., 1991; Aruffo et al., 1991) , 3-sulfated galactosylceramides synthesized by neutrophils and present in a vesicular compartment of nearly all cells undergoing active division either in vivo or in culture (Aruffo et al., 1991; A. Aruffo, W. Kolanus, and B. S., unpublished data). Cells with intracellular sulfatide pools rapidly assimilate inorganic sulfate into glycolipids and excrete them by an as yet uncharacterized mechanism, leading to the rapid accumulation of sulfated lipids in the extracellular space (Aruffo et al., 1991; A. Aruffo, W. Kolanus, and B. S., unpublished data). It has previously been proposed that neutrophil elaboration of sulfated glycolipids represents a mechanism for detachment of granulocytes from P-selectin once they have traversed the endothelium and are prepared to migrate into the organ parenchyma (Aruffo et al., 1991) . However, in studies aimed at exploring the role of cell surface sulfatides in P-selectin adhesion, it was also found that sodium selenate, an inhibitor of sulfate assimilation, blocked adhesion of a myeloid cell line (HL-60) to P-but not E-selectin immunoglobulin chimeras (Aruffo et al., 1991) . We show here that asimilar inhibition of P-but not E-selectin binding can be demonstrated in COS cells expressing PSGL-1 and a sLe"-specific fucosyltransferase.
Moreover, we demonstrate that HL-60 cells subjected to growth in chlorate, an inhibitor of sulfation, have significantly diminished capacity to attach and roll on P-selectin-coated surfaces under conditions of defined flow.
The sequence determinants that distinguish PSGL-1 as a P-selectin counterreceptor appear to be localized within a very short segment at the amino terminus of the molecule, which contains three consensus sites for tyrosine sulfation (Sako et al., 1993; Huttner, 1987) and two possiblesitesforo-linkedglycan addition. Thisfinding isconsistent with reports (Ma et al., 1994; Moore et al., 1995) that some monoclonal antibodies that specifically recognize PSGL-1 are capable of blocking binding, a result that sup-ports the view that the binding site is relatively localized. Elimination of the tyrosines strongly compromises P-selectin binding and concomitantly blocks the incorporation of sulfate into fusion proteins bearing the amino-terminal PSGL-1 domain, suggesting that tyrosine sulfate on the protein backbone, and sLeX on an O-linked glycan, may be jointly sufficient to constitute P-selectin-binding activity. Some residual activity can be seen among constructs in which the threonines but not tyrosines have been mutated, which may reflect the potential utilization of adjacent threonines of the mucin stalk for glycan presentation. It may also be that both tyrosine and glycan sulfations are required for P-selectin-binding activity. No sulfation of fusion proteins was seen when the tyrosine residues were mutated, but the possibility that glycan and tyrosine sulfations are linked for that sequence context, or that the sulfation of native mucins is independent of tyrosine sulfation, cannot be excluded. Unfortunately, metabolic inhibitors capable of discriminating between tyrosine and glycan sulfations have not been described to our knowledge.
Although studies with N-glycanase have shown that N-linked glycans are dispensable for P-selectin-binding activity (Moore et al., 1992) , the possibility that the threonines of the active peptide could be replaced by N-linked glycan addition sites has not been excluded. Nonetheless, the evidence is compelling that both a fucosylated, sialylated glycan and a motif directing the appearance of sulfated tyrosine are important for binding.
Where on P-selectin would these structures interact? The suggestion that two distinct elements may form a site for P-selectin interaction naturally suggests there may be discrete locations on P-selectin that bind to different components of the PSGL-1 ligand. A reasonable hypothesis might be that the tyrosine sulfates interact with some element of the epidermal growth factor (EGF)-like domain, whereas the sLe" interacts with the lectin domain. Some support for this hypothesis can be found in the report that the L-and P-selectin EGF-like domains are not interchangeable for ligand recognition, suggesting that these domains may directly interact with distinct features of the selectin ligands (Kansas et al., 1994) . Concurrent interaction of two or more components of PSGL-1 with P-selectin lectin domain residues may also take place. A more exotic possibility is that the two PSGL-1 components interact with a largely contiguous surface of P-selectin in a stereotyped temporal sequence, for example, in which the glycan forms a rapidly reversible link followed by displacement by, or coalescence with, the tyrosine sulfate site. Finally, sulfation may effect global changes in amino-terminal domain structure that either influence the subsequent disposition of glycans on the apical residues, or affect the conformation of peptide determinants critical for proteinprotein interaction.
Experimental Procedures
Production of Soluble P-and E-Selectin Chimeras P-and E-selectin immunoglobulin chimeras were prepared as previously described (Aruffo et al., 1991; Walz et al., 1990) . The PSGL-1 cDNA coding sequence was obtained by PCR from an HL-60 cDNA library and confirmed by DNA sequencing.
The coding segment for the mature extracellular, transmembrane, and intracellular domain was inserted in an expression vector based on CDM8 that lacks the polyoma virus origin of replication and contains the leader sequence for the CD5 antigen positioned just upstream of the coding region for a flu peptide (Field et al., 1988) epitope tag (J. Haas and 6. S., unpublished data).
Construction
of Large Scale PSGL-1 Deletions Amino-terminal PSGL-1 deletion constructs were prepared by PCR using primers encoding the desired deletion endpoint downstream of an Xbal site in frame two (encodes leucine aspartic acid). The resulting sequences encoded a polypeptide in which the residues listed below immediately followed the aspartic acid (D) of the Xba site: Al 18, Al 28, A138, Al48,Al58, A168, G178,A188,Al98,A208, A218,A228,A238, A248, A258, and T268 of the PSGL-I precursor.
The PCR fragments were inserted in the CD5 leader flu tag expression vector used for expression of the intact PSGL-1. The flu tag terminates in an Xbal site in the frame described above. Sequences at the flu tag junction were verified, and expression was confirmed in COS cells by indirect immunofluorescence microscopy and flow cytometry. A series of internal deletions with an EcoRl site at the site of the deletion in frame one (encodes glutamic acid phenylalanine) was also prepared by first creating deletion variants with amino termini (residues immediately following phenylalanine
[F] of the EcoRl site) corresponding to Al 18, A128,A138,A148,A158,A168,G178,A188,A198,A208,A218,A228, A238, A248, and A258 of the peptide sequence of the precursor.
To each of these deleted variants was appended a flu-tagged aminoterminal PSGL-1 domain ending with an EcoRl site in the glutamic acid phenylalanine frame immediately downstream of PSGL-1 precursor Al 17. The resulting constructs contain deletions between Al 17 and the various endpoints above.
Mucin Domain Interchanges CD34, CD43, and GlyCAM-1 mucins were prepared for addition of the PSGL-1 amino-terminal domain by appending an EcoRl site to either the mature amino terminus (CD34 or GlyCAM-1), or to the beginning of a region of threoninelproline-rich repeats (CD43). As above, the EcoRl site was in the frame glutamic acid phenylalanine (frame 1). The CD34 sequence began at residue F30 of the precursor, the Gly-CAM-l at precursor Ll9, and the CD43 at precursor 1135. To each of these was appended the flu-tagged PSGL-1 domain terminating in EcoRl as above. The amino terminus and repeat elements of PSGL-1 were appended to the membrane proximal, transmembrane, and intracellular domains of CD43 through an EcoRl site in the glutamic acid phenylalanine frame positioned immediately upstream of the sequences 5225 of the CD43 precursor.
The complementary fragment from PSGL-1 corresponded to the amino-terminal residues of the precursor up to T267.
Fine Structure
Mapping of the Amino-Terminal Domain A similar strategy was employed for the construction of deletions in the amino-terminal domain, in which PCR generated deletions were formed using primers bearing an Xba site in the leucine aspartic acid frame (frame 2). Immediately downstream of the residues encoding aspartic acid were the PSGL-1 sequences corresponding to precursor R38, E58, P78, and A98. For the definition of the amino-terminal domain, duplex oligonucleotides were synthesized corresponding to the residues between 38 and 57 with the indicated sequence changes to mutate threonine or tyrosine residues to alanine or phenylalanine. All constructs were confirmed by dideoxy sequencing.
Cell Adhesion Assays Transfected cells were detached from culture dishes with 0.5 mM EDTA in PBS 48-60 hr after transfection and loaded with 100 pl of %r04 (1 mCi/ml; DuPont, Boston, MA) in 0.9% NaCl plus 100 pl of medium at 37OC for 1 hr. Loaded cells were washed twice in PBS and resuspended in 0.2% BSA, 0.15 M NaCI, 3 mM CaCl>. Variation in labeling rate was typically minimal between cells prepared in parallel with the same batch of labeled chromate.
The labeled cells were incubated in wellsof 96-well microculture platescoated with affinity-purified goat anti-human by DEAE dextran and incubated immediately following transfection in DMEM containing 10% calf serum and 10 mM sodium chlorate. After trypsinization a day after transfection, the cells were incubated in fresh dishes in the same medium for 6 hr, whereupon the medium was removed, cells were washed with PBS, and incubated 18 hrfurther in acustom prepared DMEM medium (Life  Technologies) lacking sulfate and containing 2% of the usual levels of cysteine and methionine with 10% dialyzed fetal bovine serum in the presence of 10 mM sodium chlorate (Baeuerle and Huttner, 1986) . Cells were then harvested for adhesion and immunofluorescence as described.
Control cells were treated similarly, but were incubated in DMEM containing undialyzed serum.
HL-60 Cell Rolling
Video images of HL-60 cells rolling through a parallel plate rectangular flow chamber (FCS2, Bioptechs, Incorporated, Butler, PA) with a temperature controlled stage set at 37OC were acquired with an AIMS Technology (Bronx, NY) CCD camera mounted on a Zeiss ICM 405 inverted microscope equipped with a 2.5 x objective. The chamber height was 250 pm. Cells were withdrawn through the chamber at a defined flow rate with the aid of a Harvard Apparatus (South Natick, MA) model I/W 22 syringe pump. Images were analyzed using NIH Image. To inhibit sulfation, HL-60 cells were washed once with PBS and grown for 18 hr in sulfate-free medium containing 2% of the normal levels of cysteine and methionine, 10 mM sodium chlorate, and dialyzed serum as described above. For each experiment, 106 cells were suspended in 1 ml of 0.15 M NaCI, 3 mM CaC12 and drawn through the chamber. Glass coverslips were coated with affinity-purified goat anti-human IgG antibody at a concentration of 10 pg/ml in 50 mM Tris-HCI (pH 9.0) for 2 hr, washed twice with PBS, and blocked overnight with 0.2% BSA in PBS. The treated coverslips were then immersed in supernatants of COS cells transfected with the appropriate immunoglobulin chimera expression plasmids, washed twice with PBS, and assembled in the flow chamber.
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